# Bisoprolol

## CONCOR 5mg

| 藥物代碼           | OCON                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | 1.25 mg & 2.5 mg tab Stable chronic moderate to severe heart failure. 5 mg & 10 mg tab Management of hypertension, angina pectoris & stable, chronic moderate to severe heart failure (NYHA class III, IV).                                                                                                                                                                                                                                                                                                                                                     |
| 副作用             | Feeling of coldness or numbness in the extremities, nausea, vomiting, diarrhea, constipation. Tiredness, exhaustion, dizziness, headache (occur at the beginning of the therapy & usually disappear within 1-2 weeks).Gastrointestinal: Diarrhea (2.6% to 3.5% )Neurologic: Headache (8.8% to 10.9% )Respiratory: Rhinitis (2.9% to 4% ), Upper respiratory infection (4.8% to 5% .)Other: Fatigue (6.6% to 8.2%)                                                                                                                                               |
| 禁忌               | Acute heart failure or during episodes of heart failure decompensation requiring IV inotropic therapy, cardiogenic shock, AV block of grades II & III (without pacemaker), sick sinus syndrome, SA block, bradycardia with < 60 beats/min; severe bronchial asthma or severe COPD, hypotension (systolic BP < 100 mmHg), advanced stages of peripheral arterial circulatory disturbance & Raynaud's syndrome, untreated pheochromocytoma, metabolic acidosis.                                                                                                   |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 用法用量           | Hypertension, angina pectoris 5-10 mg once daily. Max: 20 mg daily. Stable chronic heart failure Patient must be treated at optimal dose with an ACE inhibitor, a diuretic, & optionally cardiac glycosides, prior to the administration of bisoprolol. Titrate gradually as follows: 1.25 mg once daily for 1 week, if well tolerated then increase to 2.5 mg once daily for 1 week, then 3.75 mg once daily for 1 week, then 5 mg once daily for 4 weeks, then 7.5 mg once daily for 4 weeks, then 10 mg once daily as maintenance therapy. Max: 10 mg daily. |
| 肝功能異常         | 無需調整劑量  建議初始劑量: 2.5 mg ORALLY once daily 最高劑量:10 mg ORALLY once daily                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 孕期用藥建議       | Human data suggest risk in 2nd and 3rd trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

## Concor 1.25mg康肯錠

| 藥物代碼           | OCON1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | 1.25 mg & 2.5 mg tab Stable chronic moderate to severe heart failure. 5 mg & 10 mg tab Management of hypertension, angina pectoris & stable, chronic moderate to severe heart failure (NYHA class III, IV).                                                                                                                                                                                                                                                                                                                                                     |
| 副作用             | Feeling of coldness or numbness in the extremities, nausea, vomiting, diarrhea, constipation. Tiredness, exhaustion, dizziness, headache (occur at the beginning of the therapy & usually disappear within 1-2 weeks).Gastrointestinal: Diarrhea (2.6% to 3.5% )Neurologic: Headache (8.8% to 10.9% )Respiratory: Rhinitis (2.9% to 4% ), Upper respiratory infection (4.8% to 5% .)Other: Fatigue (6.6% to 8.2%)                                                                                                                                               |
| 禁忌               | Acute heart failure or during episodes of heart failure decompensation requiring IV inotropic therapy, cardiogenic shock, AV block of grades II & III (without pacemaker), sick sinus syndrome, SA block, bradycardia with < 60 beats/min; severe bronchial asthma or severe COPD, hypotension (systolic BP < 100 mmHg), advanced stages of peripheral arterial circulatory disturbance & Raynaud's syndrome, untreated pheochromocytoma, metabolic acidosis.                                                                                                   |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 用法用量           | Hypertension, angina pectoris 5-10 mg once daily. Max: 20 mg daily. Stable chronic heart failure Patient must be treated at optimal dose with an ACE inhibitor, a diuretic, & optionally cardiac glycosides, prior to the administration of bisoprolol. Titrate gradually as follows: 1.25 mg once daily for 1 week, if well tolerated then increase to 2.5 mg once daily for 1 week, then 3.75 mg once daily for 1 week, then 5 mg once daily for 4 weeks, then 7.5 mg once daily for 4 weeks, then 10 mg once daily as maintenance therapy. Max: 10 mg daily. |
| 肝功能異常         | 無需調整劑量  建議初始劑量: 2.5 mg ORALLY once daily 最高劑量:10 mg ORALLY once daily                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 孕期用藥建議       | Human data suggest risk in 2nd and 3rd trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

